2480 — Beijing Luzhu Biotechnology Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$4.61bn
- HK$4.44bn
Annual balance sheet for Beijing Luzhu Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 564 | 582 | 608 | 454 | 419 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 574 | 601 | 621 | 473 | 439 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 142 | 292 | 488 | 557 | 588 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 726 | 1,070 | 1,167 | 1,050 | 1,040 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 23.4 | 94.1 | 96.3 | 98.9 | 118 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,310 | 133 | 146 | 197 | 379 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | -585 | 937 | 1,021 | 854 | 660 |
| Total Liabilities & Shareholders' Equity | 726 | 1,070 | 1,167 | 1,050 | 1,040 |
| Total Common Shares Outstanding |